Goutam Neuro Care Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 7.00 M
- Company Age 5 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.58 Cr
About Goutam Neuro Care
Goutam Neuro Care Private Limited (GNCPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 October 2019 (Five years and three months 28 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 7.00 M.
The company currently has active open charges totaling ₹2.58 Cr.
Uday Nookathota and Neeraja Alluri serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85100TG2019PTC136456
- Company No.
136456
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Oct 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Goutam Neuro Care?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Uday Nookathota  | Director | 30-Oct-2019 | Current |
| Neeraja Alluri | Director | 30-Oct-2019 | Current |
Financial Performance of Goutam Neuro Care.
Goutam Neuro Care Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Goutam Neuro Care?
In 2020, Goutam Neuro Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Goutam Hospitals Hyderabad Private LimitedUday Nookathota is a mutual person
- Gk Celestia Pharma Private Limited
Uday Nookathota is a mutual person
- Goutam Neuro Care Kompally Private Limited
Uday Nookathota is a mutual person
Charges (Loans)
₹2.58 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 1.95 Cr
- Others : 0.63 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 May 2023 | Others | ₹4.11 M | Open |
| 30 Dec 2022 | Others | ₹2.20 M | Open |
| 08 Oct 2020 | State Bank Of India | ₹1.95 Cr | Open |
How Many Employees Work at Goutam Neuro Care?
Goutam Neuro Care has a workforce of 4 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Goutam Neuro Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Goutam Neuro Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.